Skip to content

Randomized controlled clinical pilot study for the implementation of medical group visits in Germany following the CHCC-Model (Cooperative Health Care Clinics) for the treatment of patients with diabetes type II or hyper tonus in family practice

Randomized controlled clinical pilot study for the implementation of medical group visits in Germany following the CHCC-Model (Cooperative Health Care Clinics) for the treatment of patients with diabetes type II or hyper tonus in family practice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004346
Enrollment
384
Registered
2012-10-04
Start date
2013-08-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I10 E11

Interventions

Group 1: Patients of Intervention Physicians, treated in group visits every second month over the period of 12 month. Group 2: Patients of Intervention Physicians, not treated in group visits but in r

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
55 Years to No maximum

Inclusion criteria

Inclusion criteria: I. patients chronically suffering from a. diabetes, defined as an HbA1C level larger than 8,5 % or b. hyper tonus, defined as a level of mmHg larger than 140/90; it is sufficient if either the systolic or diastolic blood pressure value is exceeded, II. patients older than 55 years (born in or before 1957), III. patients who visit their family physician most frequently, defined as 10 or more visits in connection with their chronic disease within the last 12 month, IV. willingness to participate in medical group visits.

Exclusion criteria

Exclusion criteria: I. patients are terminally ill, II. patients, who are unable to follow a discussion respectively who are unable to actively participate in medical group visits – be it out of cognitive impairment, dementia, deafness insufficient language skills or other reasons, III. patients, who’s discretion in regards to the medical information’s of other patients are in question, IV. patients, who are not interested in sharing their medical histories or issues in a group with other patients, V. patients, who do not have transportation means to attend group visits on a regular basis, VI. patients, who for other reasons are unable to attend group visits on a regular basis, VII. patients, who are unable to participate in the study over the entire course of the study, VIII. patients, who at the same time participate in a second clinical trial or who just completed a different clinical trial, IX. patients, who did not consented to the participate by signing the consent form

Design outcomes

Primary

MeasureTime frame
Acceptance for Group-Visits on the patients' and physicians' side: Patient satisfaction (questionnaire) Physician satisfaction (interview) at the end of study

Secondary

MeasureTime frame
Family Physicians effectiveness: Number of family physician visits counted by members of the physician office over the course of the study

Countries

Germany

Contacts

Public ContactBenedikt Simon
b.simon@gruppensprechstunde.de015775374666

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026